Teng Fei

28PUBLICATIONS
292CO-AUTHORS
Predictive and prognostic markersMedical bacteriologyTransplantation immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Apr 06, 2026
Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Sigrun Einarsdottir, Teng Fei, Katina H Singh

|Feb 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

Jakob Wirbel, Wael Saber, Michael J Martens

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

Pageof 5

Frequent Collaborators

14 joint publications

Miguel-Angel Perales

14 joint publications

Jonathan U Peled

12 joint publications

Marcel R M van den Brink

9 joint publications

Roni Shouval